WHO ICTRP trial
Randomized double-blind, placebo-controlled clinical trial for Bu-Shen Jiang-Ya…
ChiCTR1900028572 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1900028572 |
|---|---|
| Public title | Randomized double-blind, placebo-controlled clinical trial for Bu-Shen Jiang-Ya Granules in treating patients with essential hypertension of kidney deficiency type |
| Scientific title | Randomized double-blind, placebo-controlled clinical trial for Bu-Shen Jiang-Ya Granules in treating patients with essential hypertension of kidney deficiency type |
| Primary sponsor | Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | essential hypertension |
| Interventions | Experimental group:Amlodipine besylate tablets plus Bu-Shen Jiang-Ya Granules;Control group:Amlodipine besylate tablets plus placebo |
| Registration date | Dec 27, 2019 |
| Target size | Experimental group:40;Control group:40 |
| Secondary IDs | ChiMCTR1900002876 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: